Injectable Drug Delivery to 2024


On-Body Subcutaneous injection systems   Injectable Drug Delivery to 2024 •  November 2018 • (JDF838K) • US $4,850

The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions.  Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. The trend toward self-administration of injectables will exert increasing influence on all aspects of the parenteral drug sector.

Bar_Graph  Injectable Drug Delivery to 2024 Report Brochure (Download PDF)

Blue document  Injectable Drug Delivery to 2024 Report Order Form (Download PDF)

  Click here to Order Online


Injectable Drug Delivery to 2024 – What You Will Learn

• What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
• What are the market drivers influencing syringes and injectors – device designs, feature/functionality, product branding, competing technologies and commercial development?
• What are the key characteristics of the major injectable device market segments and what is the impact of market demographics, and competing business strategies?
• What is the current market demand for syringes and injectors by indication and therapy and what will it be in 2024?
• Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
• What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?

Injectable Drug Delivery to 2024 – Summary of Contents

Executive Summary

Injectable Drug Market Dynamics
Evolution in Drug Development
Injectables Demand Drivers
Diseases and Indications
Population Demographics
Competitive landscape
Risks & Opportunities
Technology Risks
Market Risks
Regulatory Risks

Device Design & Selection Factors
Market Segmentation
Product Features & Ease of Use
Supply Chain Factors
Capabilities & Market Presence
Regional Market Factors
Design Requirements
Design Ergonomics
Patient Safety
Dosing Frequency
Drug Stability & Shelf Life
Drug Reconstitution
Fixed vs Variable Dose Devices

Competing Injection Device Classes
Prefilled Syringes (PFS)
Glass PFS
Plastic PFS
Standard PFS Compatible
Custom Design
Reusable vs Disposable Designs
Dual Chamber Syringes 
Needle-free Injectors (NFI)
Prefilled NFI
Reusable vs Disposable Designs
Pen Injectors
Branded Custom Pens
OEM Devices

Patch Pumps
Mechanical vs Electronic
Disposable vs Reusable
Prefilled vs Patient Fillable
Subcutaneous Infusion Devices
Mechanical vs Electronic
Disposable vs Reusable
Volume/Viscosity Capabilities
Patient Interface
Injection Methodology
Primary Container
Duration Dependent Dosing
Device Segmentation
OEM Devices
Captive Devices
Product Specific Devices

Trending Specialty Injectable
Device Capabilities
Communication-enabled Devices
High Viscosity Capable Devices
Large Volume Wearable Devices
Drug Injection Device Market Segment Analysis & Forecasts
Autoimmune Diseases
Emergency Medicine
Hormone Replacement
Reproductive Health

Market Factors
Regulatory Issues
Device Branding
Patient Compliance
Healthcare Economics
Partnerships and Alliances

Company Profiles